Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Cardiac amyloidosis has a wide spectrum of clinical manifestations but the ...
Cardiac amyloidosis is a condition that occurs when abnormal proteins called "amyloid" build up in your heart. These proteins can develop and grow in the heart tissue, increasing your risk for ...
The prognosis of patients with cardiac amyloidosis is affected by their cardiac condition, the extracardiac involvement and the modality of treatment of the underlying disease. Another predictor ...
Renton, Wash.-based Providence Heart Institute's new Howard "H" White Center for Cardiac Amyloidosis has received a $1 million donation from former NBA star Michael Jordan.
Michael Jordan, the icon behind Nike’s most successful brand, donated $1 million to Portland’s Providence Heart Institute to establish a cardiac disease center. Jordan’s seven-figure donation will ...
The NEXICART-2 study is intended to evaluate the safety and efficacy of NXC-201 in relapsed/refractory AL Amyloidosis patients with adequate cardiac function who have not been exposed to prior ...